CIK 0001427570 · <br>Emerging growth company
Vyome Holdings, Inc
Sign in to watch- Ticker
- HIND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-429-6680
- Business address
- 1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
- Former names
- ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-16 | HOWE LESLEY H Director | Grant or award · Stock Option | +27,250 | 27,250 | ||
| 2020-09-16 | HOWE LESLEY H Director | Grant or award · Stock Option (Right to Buy) | +27,250 | 27,250 | ||
| 2020-09-16 | DITTAMORE RAYMOND V Director | Grant or award · Stock Option | +27,250 | 27,250 | ||
| 2020-09-16 | DITTAMORE RAYMOND V Director | Grant or award · Stock Option (Right to Buy) | +27,250 | 27,250 | ||
| 2020-09-16 | Plovanic William J. Director | Grant or award · Stock Option | +27,250 | 27,250 | ||
| 2020-09-16 | Plovanic William J. Director | Grant or award · Stock Option (Right to Buy) | +27,250 | 27,250 | ||
| 2020-09-16 | Kamdar Kim P. Director | Grant or award · Stock Option | +27,250 | 27,250 | ||
| 2020-09-16 | Kamdar Kim P. Director | Grant or award · Stock Option (Right to Buy) | +27,250 | 27,250 | ||
| 2020-06-23 | Hussainy Nooshin Chief Financial Officer | Grant or award · Stock Option | +52,865 | 52,865 | ||
| 2020-06-23 | Hussainy Nooshin Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +165,135 | 165,135 | ||
| 2020-06-23 | Rasdal Andrew P President, CEO & Exec Chairman | Grant or award · Stock Option | +52,865 | 52,865 | ||
| 2020-06-23 | Rasdal Andrew P President, CEO & Exec Chairman | Grant or award · Stock Option (Right to Buy) | +165,135 | 165,135 | ||
| 2020-01-24 | Plovanic William J. President & CEO | Grant or award · Restricted Stock Units | +441,125 | 441,125 | ||
| 2020-01-24 | MacDonald Robert J Chief Retail Officer | Grant or award · Restricted Stock Units | +88,225 | 88,225 | ||
| 2020-01-24 | VandenBerg Amy Chief Clinical & Reg Officer | Grant or award · Restricted Stock Units | +88,225 | 88,225 | ||
| 2020-01-24 | Hussainy Nooshin Chief Financial Officer | Grant or award · Restricted Stock Units | +88,225 | 88,225 | ||
| 2020-01-24 | Brister Mark Chief Technology Officer | Grant or award · Restricted Stock Units | +110,281 | 110,281 | ||
| 2019-11-12 | Plovanic William J. President & CEO | Purchase | +65,000 | $1.66 | $108K | 106,806 |
| 2019-10-25 | Brister Mark Chief Technology Officer | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2019-10-25 | VandenBerg Amy Chief Clinical & Reg Officer | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 7 of 10 · 185 trades